Category Archives: Events

Latest From Events

BIO Patient & Health Advocacy Summit: The Power of Partnerships

patient-summit-4

This week, the BIO Patient & Health Advocacy Summit powered partnerships in the industry to advance drug discovery by bringing together patient advocacy organizations, government agencies and industry leaders to discuss how to accelerate R&D, preserve patient access, leverage data and build collaborations focused on empowering patients. The rallying cry that reverberated throughout the event and over Twitter seemed clear from the beginning and Paul Hastings, Chairman and CEO of OncoMed Pharmaceuticals, Inc. captured it Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Richard Pops: A Greater Patient Voice in Drug Development

ph-summit

In the October issue of MedNous, Alkermes’ CEO Richard Pops writes about the move toward increased engagement with patients in the development, review and delivery of new medicines, as well as the challenges and opportunities associated with access and reimbursement. Pops asserts that patients must organize to share data that can be used in regulatory decision-making. Furthermore, he writes that this input must be integrated through the process – from the early stages of development Read More >

Events, Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

STEM Career Symposium Coming to Maryland

ATLAS

The Tech Council of Maryland and MdBio Foundation will soon be hosting a symposium for students typically underrepresented in Science, Technology, Engineering, and Math (STEM) fields. The ATLAS symposium will allow students and parents to explore rewarding careers in STEM. Participants meet STEM professionals from a variety of backgrounds and fields through panels and networking sessions. Participants will also have the opportunity to discuss college, internship, and career opportunities with representatives from local universities, companies, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

BIO Investor Forum Closing Plenary: How Fragile is the Biotech Rally After Five Positive Years?

2

Last week’s 13th Annual BIO Investor Forum closed on Wednesday with a plenary session asking, “How fragile is the biotech rally after five positive years?” Moderated by Todd Foley, Managing Director, MPM Capital, the panel included: Rachel King, CEO, GlycoMimetics and Chair, BIO Ellen Lubman, VP Strategy and Innovation, Forest Laboratories Vijay Murthy, Director, Ventures and Early Stage Collaborations, AbbVie Michael A. Margolis, RPh, Managing Director, ROTH Capital Partners Doug Fambrough, PhD, CEO, Dicerna Pharmaceuticals Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , ,

A Patient at BIO Investor Forum

BIF-2014

“Sir?” The security guard walks to the Partnering desk, slightly confused. “Sir, there’s a man with no badge. He says he’s not registered for the conference. But he says he needs to talk to you.” At BIO events, you can always expect the unexpected. I nod to the guard. “Let him in.” A man. 70s. Stooped; hunched; gnarled. Disheveled. Faded tattoos on his forearms. Yet, a twinkle in his eye and an unexpected motorcycle helmet Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,